Search Result "Antiparkinsonian Agents"

The Use of Antiparkinsonian Agents in the Management of Drug-Induced Extrapyramidal Symptoms

Journal: Current Pharmaceutical Design
Volume: 10 Issue: 1 Year: 2004 Page: 2239-2248
Author(s): K. Burgyone, K. Aduri, J. Ananth, S. Parameswaran

Parkinson Disease and Antiparkinsonian Drugs

Ebook: Medicinal Chemistry for Pharmacy Students
Volume: 2 Year: 2020
Author(s): Ashok E. Philip,George DeMaagd,M. O. Faruk Khan
Doi: 10.2174/9789811454073120020010

Research Article

Antiparkinsonian Potential of Natural Products: Molecular Docking,Prediction of Pharmacokinetic and Toxicological Properties

Journal: Current Physical Chemistry
Volume: 13 Issue: 1 Year: 2023 Page: 75-89
Author(s): Henrique B. Lima,Jaderson V. Ferreira,Mariela L. Nery,Gisele A. Chaves,Anderson L. P. da Costa,Lucilene R. de Souza,Bianca L. Marino,Maiara F.B. Brito,Hueldem R.C. Teixeira,Carlos H.T.P. Silva,Carlton A. Taft,Lorane I.S. Hage-Melim

3-Methyl-6-(prop-1-en-2-yl)cyclohex-3-ene-1,2-diol: the Importance of Functional Groups for Antiparkinsonian Activity

Journal: Medicinal Chemistry
Volume: 9 Issue: 5 Year: 2013 Page: 731-739
Author(s): Oleg V. Ardashov,Alla V. Pavlova,Dina V. Korchagina,Konstantin P. Volcho,Tat’ yana G. Tolstikova,Nariman F. Salakhutdinov

Medicinal Plants and Natural Compounds as Antiparkinsonian Agents

Ebook: Neurodegenerative Diseases: Multifactorial Degenerative Processes, Biomarkers and Therapeutic Approaches (First Edition)
Volume: 1 Year: 2022
Author(s): Saumitra Sen Singh,Aaina Singh Rathore,Priyanka Kumari Keshri,Surya Pratap Singh
Doi: 10.2174/9789815040913122010014

Piribedil: Antiparkinsonian Properties and Potential Clinical Utility in Dopaminergic Disorders

Journal: Current Drug Therapy
Volume: 6 Issue: 1 Year: 2011 Page: 17-34
Author(s): Aravind Mittur

Research Article

A New Series of 1,3-Dimethylxanthine Based Adenosine A2A Receptor Antagonists as a Non-Dopaminergic Treatment of Parkinson’s Disease

Journal: Current Drug Discovery Technologies
Volume: 18 Issue: 5 Year: 2021 Page: 3-13
Author(s): Suman Rohilla,Ranju Bansal,Puneet Chauhan,Sonja Kachler,Karl-Norbert Klotz

The Intranasal Administration of 1-Methyl-4-Phenyl-1,2,3,6-Tetrahydropyridine (MPTP): A New Rodent Model to Test Palliative and Neuroprotective Agents for Parkinsons disease

Journal: Current Pharmaceutical Design
Volume: 17 Issue: 5 Year: 2011 Page: 489-507
Author(s): Rui D. S. Prediger, Aderbal S. Aguiar, Eduardo L. G. Moreira, Filipe C. Matheus, Adalberto A. Castro, Roger Walz, Andreza F. De Bem, Alexandra Latini, Carla I. Tasca, Marcelo Farina, Rita Raisman-Vozari

Review Article

Different Generations of Type-B Monoamine Oxidase Inhibitors in Parkinson’s Disease: From Bench to Bedside

Journal: Current Neuropharmacology
Volume: 17 Issue: 9 Year: 2019 Page: 861-873
Author(s): Marika Alborghetti,Ferdinando Nicoletti

Substance Abuse and Movement Disorders: Complex Interactions and Comorbidities

Journal: Current Drug Abuse Reviews
Volume: 5 Issue: 3 Year: 2012 Page: 243-253
Author(s): Andres Deik,Rachel Saunders-Pullman,Marta San Luciano

Previous   Next

Go To   Results 1 - 1 of 259

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2024 Bentham Science Publishers | Privacy Policy